ES2193210T3 - Separacion de virus de soluciones de proteinas por ultrafiltracion. - Google Patents

Separacion de virus de soluciones de proteinas por ultrafiltracion.

Info

Publication number
ES2193210T3
ES2193210T3 ES96100268T ES96100268T ES2193210T3 ES 2193210 T3 ES2193210 T3 ES 2193210T3 ES 96100268 T ES96100268 T ES 96100268T ES 96100268 T ES96100268 T ES 96100268T ES 2193210 T3 ES2193210 T3 ES 2193210T3
Authority
ES
Spain
Prior art keywords
viruses
ultrafiltration
separation
protein solutions
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96100268T
Other languages
English (en)
Inventor
Dieter Dr Bernhardt
Albrecht Dr Groner
Thomas Dr Nowak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
Aventis Behring GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7753509&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2193210(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Behring GmbH filed Critical Aventis Behring GmbH
Application granted granted Critical
Publication of ES2193210T3 publication Critical patent/ES2193210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

LA INVENCION TRATA DE LA RETIRADA DE VIRUS POR ULTRAFILTRACION DE SOLUCIONES ACUOSAS, GENERALMENTE SOLUCIONES PROTEINICAS. LOS VIRUS RETIRADOS AUMENTAN POR INCUBACION CON UN ANTICUERPO DE ALTO PESO MOLECULAR Y ESPECIFICO. DE ESTA MANERA, POR UN LADO SE MEJORA EL EFECTO DE SEPARACION, Y POR OTRO LADO SE POSIBILITA LA ELECCION DE UN DIAMETRO DE PORO MAYOR, PUDIENDO RETIRAR VIRUS MAS PEQUEÑOS QUE SE ENCUENTRAN EN LA SOLUCION PROTEINICA, Y PROPORCIONA OPCIONALMENTE UNA MAYOR VELOCIDAD DE FILTRACION.
ES96100268T 1995-02-09 1996-01-10 Separacion de virus de soluciones de proteinas por ultrafiltracion. Expired - Lifetime ES2193210T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19504211A DE19504211A1 (de) 1995-02-09 1995-02-09 Entfernen von Viren durch Ultrafiltration aus Proteinlösungen

Publications (1)

Publication Number Publication Date
ES2193210T3 true ES2193210T3 (es) 2003-11-01

Family

ID=7753509

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96100268T Expired - Lifetime ES2193210T3 (es) 1995-02-09 1996-01-10 Separacion de virus de soluciones de proteinas por ultrafiltracion.

Country Status (9)

Country Link
US (2) US20020068368A1 (es)
EP (1) EP0727226B1 (es)
JP (1) JPH08242849A (es)
KR (1) KR100421763B1 (es)
AT (1) ATE236659T1 (es)
AU (1) AU708757B2 (es)
CA (1) CA2169122A1 (es)
DE (2) DE19504211A1 (es)
ES (1) ES2193210T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709186C2 (de) 1997-03-06 1999-10-14 Medigene Ag Filtrationsverfahren zur Trennung von Viren
WO2001014047A1 (en) * 1999-08-20 2001-03-01 Asahi Kasei Kabushiki Kaisha Filter membranes for physiologically active substances
US6861001B2 (en) * 1999-12-02 2005-03-01 The General Hospital Corporation Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
SI1453857T1 (sl) * 2001-11-28 2015-01-30 Sandoz Ag Kromatografsko čiščenje rekombinantnega človeškega eritropoetina
US20040259076A1 (en) * 2003-06-23 2004-12-23 Accella Scientific, Inc. Nano and micro-technology virus detection method and device
EP2029741A4 (en) * 2006-06-08 2011-03-16 Merck Sharp & Dohme QUICK PROCEDURE FOR DETERMINING THE HEMMERSENSITIVITY OF NS3 / 4A PROTEASE SEQUENCES CLONED FROM CLINICAL SAMPLES
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896218A (en) * 1972-07-13 1975-07-22 Research Corp Radiommunoassay determining the hepatitis associated antigen content of blood
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
US4692411A (en) * 1983-09-06 1987-09-08 Ghose Rabindra N Separation of specific biological cells by a biochemical filter
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
US4808315A (en) * 1986-04-28 1989-02-28 Asahi Kasei Kogyo Kabushiki Kaisha Porous hollow fiber membrane and a method for the removal of a virus by using the same
US4857196A (en) * 1987-08-07 1989-08-15 Asahi Kasei Kogyo Kabushiki Kaisha Porous hollow fiber membrane and a method for the removal of a virus by using the same
EP0477302B1 (en) * 1989-06-15 1995-02-01 SMITH, William I. Jr. Apparatus for inactivating infectious agents in and resisting coagulation of biological fluids
DE4003543A1 (de) * 1990-02-06 1991-08-08 Orpegen Med Molekularbioforsch Verfahren zur abreicherung von viren in loesungen und zur bestimmung der abreicherungsrate von viren
JP2690802B2 (ja) * 1990-04-24 1997-12-17 オリンパス光学工業株式会社 免疫学的検査法
US5017292A (en) * 1990-05-10 1991-05-21 Millipore Corporation Membrane, process and system for isolating virus from solution

Also Published As

Publication number Publication date
JPH08242849A (ja) 1996-09-24
ATE236659T1 (de) 2003-04-15
KR100421763B1 (ko) 2004-05-10
AU708757B2 (en) 1999-08-12
US20020068368A1 (en) 2002-06-06
KR960031474A (ko) 1996-09-17
DE59610319D1 (de) 2003-05-15
US6391657B1 (en) 2002-05-21
CA2169122A1 (en) 1996-08-10
EP0727226A2 (de) 1996-08-21
EP0727226A3 (de) 1999-07-21
EP0727226B1 (de) 2003-04-09
AU4440196A (en) 1996-08-15
DE19504211A1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
ES2032802T3 (es) Sucedaneo de la sangre, semisintetico, extrapuro.
EA199700421A1 (ru) Искуственная разделительная мембрана
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
CO4910172A1 (es) Sistema de membrana de afinidad y metodo de uso del mismo
ES2099273T3 (es) Comprimidos de verapamil de liberacion controlada.
ES2157912T3 (es) Membrana y metodo para la separacion de sustancias unidas a proteinas de un liquido que contiene proteinas mediante dialisis.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
UY26335A1 (es) "envases"
CO4870770A1 (es) Tisu que contiene betaina silicona y metodo de fabricarlo
TR199701754T1 (xx) Enantiyomerik zenginle�tirilmi� benzimidazol t�revlerini optik safla�t�rma y�ntemi.
DE69838147D1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
ES2105999T1 (es) Procedimiento para la preparacion industrial de fosfatidilserina.
DE69109903D1 (de) Asymmetrische Gastrennungsmembran.
ES2057191T3 (es) Metodo de produccion para una composicion que contiene proteinas.
MX9300550A (es) Estructura de fibra absorbente.
SE9801573D0 (sv) New IOL
ES2173923T3 (es) Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente.
ES8600945A1 (es) Un aparato para la purificacion de sangre
ES2128287T3 (es) Procedimiento para la purificacion de agentes de contraste opacificadores.
AU4440196A (en) The removal of viruses from protein solutions by ultrafiltration
FR2814088B1 (fr) Membranes pour la separation selective gazeuse
ES2119747T3 (es) Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales.
DK0477284T3 (da) Fremgangsmåder til udvinding af naturligt produceret chymosin
ES2191058T3 (es) Celulas portadoras de receptores simulados de cd4, y moleculas y metodos relacionados.
NO974561D0 (no) Chlamydia-vaksine